BrightInsight Makes the 2021 CB Insights Digital Health 150 For the Second Year in Row

I’m excited to share the news that for the second year in a row, BrightInsight has been named to the CB Insights annual Digital Health 150 list. Showcasing the 150 most promising private digital health companies in the world, this year’s Digital Health 150 was unveiled live during CB Insights’ annual Future of Health event.

In 2021, our company achieved several important milestones. In March, we announced a Series C funding round of $101M bringing the total raised to $166M. The round was led by General Catalyst, the most active investor in this year’s Digital Health 150 companies. The funding helped to further supercharge our growth, tripling our valuation and accelerating further productization of our compliant Platform and software Accelerator Modules to meet growing demand from our customers. We have also tripled our team and our revenue since the Series B round. We launched digital health solutions globally with our biopharma clients including CSL Behring, Roche, Novo Nordisk, and most recently, the AMAZE Disease Management Platform with AstraZeneca that was rolled out at Mass General Brigham.

“This year’s Digital Health 150 is one of our most expansive yet, spotlighting 16 categories including virtual care, clinical trials tech, and workflow automation, as well as adding new categories such as home health tech and computer-aided imaging,” said Brian Lee, SVP of CB Insights’ Intelligence Unit. “Last year's class has seen more than 20 exits, raised an additional $18.6B in aggregate funding, and announced over 250 partnerships since being recognized, and we’re excited to see the future success of this year’s winners.”

Recognition from CB Insights reflects the growing adoption of our leading global platform for biopharma and medtech regulated digital health solutions and the work by our incredible team.

We are humbled to know that the CB Insights research team selected the Digital Health 150 from a pool of over 11,000 companies, including applicants and nominees. Through an evidence-based approach, the Digital Health 150 were chosen based on several factors, including data submitted by the companies, company business models and momentum in the market, and Mosaic scores, CB Insights’ proprietary algorithm that measures the overall health and growth potential of private companies.

I could not be prouder of our team! BrightInsight is heading into 2022 poised for growth as the healthcare market increasingly understands the value of digital health and investment in the sector continues to grow.

Blog brightinsight makes the 2021 cb insights digital health 150 for the second year in row chart
Back to Blog